CLASS II ONGOING Device recall · Reported 2 Aug 2023 · FDA Enforcement Report

QIAstat-Dx¿ Respiratory Sars-CoV-2 Panel -IVD intended recalled

Qiagen is recalling QIAstat-Dx¿ Respiratory Sars-CoV-2 Panel -IVD intended for the detection and, distributed in 17 states. The recall was initiated on 9 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 14053228038846 LOT Number: 175010712 Affected Serial numbers (SNs) are from 330559516 to 330559783
Quantity recalled368 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2215-2023
FDA event ID
92540
Recalling firm
Qiagen, Hilden, N/A
Classification
Class II
Status
Ongoing
Recall initiated
9 May 2023
FDA classified
21 Jul 2023
Reported
2 Aug 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

9 May 2023Recall initiated by company
21 Jul 2023Classified by FDA+73 days
2 Aug 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

If cartridges of the affected Serial numbers (SNs) are used, in most cases, the error codes 0xY0003EA and 0xY00045A (where Y is a number between 1 and 4) that lead to a run abortion will occur and no results will be reported

Product as listed by the FDA

QIAstat-Dx¿ Respiratory SARS-CoV-2 Panel -IVD intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the following organism types and subtypes: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, SARS-CoV-2, Human Metapneumovirus A+B, Influenza A, Influenza A H1, Influenza A H3, Influenza A H1N1/pdm09, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus A+B, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae REF 691223

Where it was distributed

AL, AR, CA, DC, FL, GA, ID, KS, KY, MD, MN, NJ, NY,PA, SC, TX, VA

AlabamaArkansasCaliforniaDistrict of ColumbiaFloridaGeorgiaIdahoKansasKentuckyMarylandMinnesotaNew JerseyNew YorkPennsylvaniaSouth CarolinaTexasVirginia

Questions about this recall

Why was it recalled?

If cartridges of the affected Serial numbers (SNs) are used, in most cases, the error codes 0xY0003EA and 0xY00045A (where Y is a number between 1 and 4) that lead to a run abortion will occur and no results will be reported

Which lots are affected?

GTIN: 14053228038846 LOT Number: 175010712 Affected Serial numbers (SNs) are from 330559516 to 330559783

Where was it sold?

AL, AR, CA, DC, FL, GA, ID, KS, KY, MD, MN, NJ, NY,PA, SC, TX, VA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Qiagen

All 6
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IItherascreen ¿KRAS RGQ PCR Kit -IVD qualitative PCR assay recalledQiagenPotency & AssayNationwide
DeviceCLASS IIQIAstat-Dx Respiratory Sars-CoV-2 Panel (V1 and V2, CE IVD recalledQiagenOther14 states
DeviceCLASS IIQIAstat-Dx Respiratory Sars-CoV-2 Panel -US IVD qualitative recalledQiagenOther14 states
DeviceCLASS IIEZ1 DSP Virus Kit , IVD recalled by QIAGENQiagenOtherDE, MD
DeviceCLASS IIQIAamp DSP Virus Kit recalled by QiagenQiagenOtherAR, DE, IN

Other CPAP & Ventilators recalls

All 552